Table 1.
Comparison of maternal characteristics of women unexposed to any of the opioids during the first trimester of pregnancy to women exposed to any of the opioids and to codeine or propoxyphene alone.
Table 2.
Unadjusted and adjusted risk (odds ratios (OR) and 95% confidence intervals (95% CI)) for congenital malformations after intrauterine exposure to opioids during the first trimester of pregnancy compared to unexposed.
Table 3.
Odds ratios for congenital malformations after intrauterine exposure to codeine or propoxyphene during the first trimester of pregnancy compared to unexposed.
Table 4.
Odds ratios for adverse pregnancy outcomes (other than malformations) following third trimester intrauterine exposure to opioids, and specifically to codeine or to propoxyphene alone, compared to unexposed.